Grupo Oncológico para el Tratamiento y Estudio de los Linfomas

GOTEL (Grupo Oncológico para el Tratamiento y Estudio de los Linfomas) is a prominent Spanish cooperative research group focused on the advancement of clinical and biological knowledge regarding lymphomas. Established in 1999, the organization serves as a collaborative platform for oncologists and hematologists to design and execute multicenter clinical trials and translational research projects. GOTEL maintains a robust portfolio of studies ranging from Phase 1 to Phase 4, often partnering with global pharmaceutical companies to evaluate innovative therapies such as targeted small molecules and immunotherapies. The group is instrumental in developing national clinical guidelines and maintaining comprehensive patient registries that inform treatment standards in Spain. Through its extensive network of participating hospitals, GOTEL significantly contributes to the optimization of diagnostic and therapeutic strategies for various lymphoma subtypes, including Hodgkin and non-Hodgkin lymphomas.